written by reader Cellectis Romainville…Biotech

By hendrixnuzzles, March 13, 2015

Does anyone have opinion or insight into Cellectis and its potential ?
Have found very little opinion or analysis available on this company, apart from their website and a few terse press announcements (Pfizer and Servier agreements, gene splicing patents, decision to offer securities in the US) and dense technical explanations of their approach to CART therapy…allegedly unique in that it is allogenic, as opposed to autologous, meaning it can use 3rd party cultured cells instead of donor cells.

From what I understand this means they can potentially deliver an off-the-shelf product instead of a ”custom” one-patient-at-a-time process…

Based on the Pfizer and Servier investments I took a small position
and got lucky, the stock jumped on the announcement of a US offering. Would appreciate any insight anyone may have…

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.



This site uses Akismet to reduce spam. Learn how your comment data is processed.

Inline Feedbacks
View all comments
March 14, 2015 1:05 am

CMVLF- hendrixnuzzles, Cellectis has been and is discussed frequently on the biotechnology threads as well as the finest other equities in this sector. The knowledge, education and camaraderie here at stockgumshoe.com is second to none. Have an excellent weekend and beyond ALL!-Benjamin

👍 11549